Viewing Study NCT03182166


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-04-05 @ 3:25 AM
Study NCT ID: NCT03182166
Status: COMPLETED
Last Update Posted: 2022-03-14
First Post: 2017-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module